Evidence map›Paper›PMID 21783425›Full record

ArticleEpilepsy & behavior : E&B2011

Fetal antiepileptic drug exposure: motor, adaptive, and emotional/behavioral functioning at age 3 years.

Morris J Cohen, Kimford J Meador, Nancy Browning, Gus A Baker, Jill Clayton-Smith, Laura A Kalayjian, Andres Kanner, Joyce D Liporace, Page B Pennell, Michael Privitera and 1 more

Open access · greenAbstract read
In one paragraph

Article in Epilepsy & behavior : E&B, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 3 pooled it
7.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 3 syntheses or guidelines pooled it, 88 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Observational
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Pregnancy and epilepsy.Continuum (Minneapolis, Minn.) · 2014
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 10 institutions in 2 countries.

Morris J CohenNeurology, Georgia Health Sciences University, Augusta, GA 30912, USA. mcohen@georgiahealth.edu
Kimford J Meador
Nancy Browning
Gus A Baker
Jill Clayton-Smith
Laura A Kalayjian
Andres Kanner
Joyce D Liporace
Page B Pennell
Michael Privitera
David W Loring
Emory University · USAugusta University Health · USBrigham and Women's Hospital · USEmmes (United States) · USRiddle Hospital · USRush University Medical Center · USSt. Mary's Hospital · GBUniversity of Cincinnati · USUniversity of Southern California · USWalton Centre · GB

Funding

NEURODEVELOPMENT EFFECTS OF ANTIEPILEPTIC DRUGSR01NS038455 · NINDS · UNIVERSITY OF FLORIDA · PI MEADOR, KIMFORD J · 2000 to 2009
$12.0M
Neurodevelopment Effects of Antiepileptic DrugsR01NS050659 · NINDS · THE EMMES COMPANY, LLC · PI BROWNING, NANCY · 2004 to 2008
$2.5M
NINDS NIH HHS 2R01-NS038455NINDS NIH HHS R01 NS038455NINDS NIH HHS R01 NS050659NINDS NIH HHS R01NS050659
6 · The paper itself

Abstract

The Neurodevelopmental Effects of Antiepileptic Drugs (NEAD) Study is an ongoing prospective observational multicenter study in the United States and United Kingdom that enrolled pregnant women with epilepsy on antiepileptic drug (AED) monotherapy from 1999 to 2004. The study seeks to determine if differential long-term neurodevelopmental effects exist across four commonly used AEDs (carbamazepine, lamotrigine, phenytoin, valproate). In this article, we examine fetal AED exposure effects on motor, adaptive, and emotional/behavioral functioning in 229 children who completed at least one of these tests at 3 years of age. Adjusted mean scores for the four AED groups were in the low average to average range for motor functioning, parental ratings of adaptive functioning, and parental ratings of emotional/behavioral functioning. A significant dose-related performance decline in motor functioning was seen for both valproate and carbamazepine. A significant dose-related performance decline in parental ratings of adaptive functioning was also seen for valproate, with a marginal performance decline evident for carbamazepine. Further, parents endorsed a significant decline in social skills for valproate that was dose related. Finally, on the basis of parent ratings of attention span and hyperactivity, children of mothers who took valproate during their pregnancy appear to be at a significantly greater risk for a future diagnosis of attention-deficit/hyperactivity disorder. Additional research is needed to confirm these findings, examine risks of other AEDs, define the risks in the neonate associated with AEDs for treatment of seizures, and determine the underlying mechanisms of adverse AED effects on the immature brain.

Indexed as

Adaptation, PsychologicalAnticonvulsantsBehavioral SymptomsChild, PreschoolDevelopmental DisabilitiesFemaleHumansMaleMovement DisordersPregnancyPrenatal Exposure Delayed EffectsRegression AnalysisAnticonvulsants

Identifiers

PMID21783425
PMCPMC3185140
OpenAlexW3109666218

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.